Tramadol Hydrochloride Tablet, Extended Release
Product Images NDC 68071-5078

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 68071-5078). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-1 (33a5de83 A974 48a5 8ba6 4c1b97515615 01)

Chemical structure of tramadol hydrochloride, showing its molecular arrangement including characteristic rings, hydroxyl group, and amine moiety along with the hydrochloride compound.*

FDA Label Image

Image-2 (33a5de83 A974 48a5 8ba6 4c1b97515615 02)

A line graph comparing Tramadol concentration (ng/mL) over 24 hours for Tramadol Hydrochloride Extended-Release Tablets 200 mg q.d. and Tramadol Hydrochloride Tablets 50 mg q6h. The x-axis shows time in hours, and the y-axis shows tramadol concentration in ng/mL. Two lines with different markers depict the concentration profiles for the two formulations over time.*

FDA Label Image

Image-3 (33a5de83 A974 48a5 8ba6 4c1b97515615 03)

A line graph depicting concentration of M1 metabolite (ng/mL) over 24 hours comparing Tramadol Hydrochloride Extended-Release Tablets 200 mg once daily (solid circles) to Tramadol Hydrochloride Tablets 50 mg every 6 hours (open circles). Concentration trends fluctuate for both formulations throughout the time course.*

FDA Label Image

Image-4 (33a5de83 A974 48a5 8ba6 4c1b97515615 04)

A line chart titled 'Tramadol Hydrochloride Extended-Release Tablets Study 023 WOMAC Pain Responder Analysis' showing percent of patients achieving response at various percent improvement thresholds. Lines represent different dosages of Tramadol Hydrochloride Extended-Release Tablets (100 mg, 200 mg, 300 mg, 400 mg) and a placebo group. The x-axis is response threshold (percent improvement from baseline), and the y-axis is percent of patients achieving response, both ranging from 0 to 100 and 0 to 60 respectively.*

FDA Label Image

Image-5 (33a5de83 A974 48a5 8ba6 4c1b97515615 05)

A line graph titled 'Tramadol Hydrochloride Extended-Release Tablets Study 015 Arthritis Pain Intensity VAS Responder Analysis' showing the percentage of patients achieving various levels of response thresholds. The x-axis represents the response threshold as percent improvement from baseline, ranging from 0 to 100%. The y-axis shows the percent of patients achieving response, ranging from 0 to 60%. Two lines compare Tramadol Hydrochloride Extended-Release Tablets and placebo, with Tramadol showing higher patient response rates across thresholds.*

FDA Label Image

Pdp (68071 5078 3)

Label for Tramadol HCl 300 mg extended-release tablets by NuCare Pharmaceuticals, Inc. Displays NDC 68071-5078-3, quantity of 30 tablets, and a control schedule IV symbol. Includes manufacturer info, storage instructions, and a warning to keep out of reach of children. Contains barcodes and QR code with lot and expiration placeholders.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.